RayzeBio, Nimble ink research collaboration

By AuntMinnie.com staff writers

June 28, 2021 -- RayzeBio and Nimble Therapeutics plan to collaborate on the discovery and development of novel peptide-based radiopharmaceuticals for cancer treatment.

The partnership will allow RayzeBio to expand its radiopharmaceutical pipeline and develop multiple therapies simultaneously, it said.

RayzeBio will pay Nimble an undisclosed upfront amount, research reimbursements, and perhaps milestone payments and royalties. RayzeBio has exclusive rights to market any peptides discovered through the collaboration, it said.

Copyright © 2021 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking